A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke

NCT00046761 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

1320

Enrollment

INDUSTRY

Sponsor class

Conditions

Cerebrovascular Accident

Interventions

DRUG: ONO-2506

Sponsor

Ono Pharma USA Inc